1. Home
  2. GRC vs NVAX Comparison

GRC vs NVAX Comparison

Compare GRC & NVAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Gorman-Rupp Company (The)

GRC

Gorman-Rupp Company (The)

HOLD

Current Price

$61.25

Market Cap

1.7B

Sector

Industrials

ML Signal

HOLD

Logo Novavax Inc.

NVAX

Novavax Inc.

HOLD

Current Price

$8.49

Market Cap

1.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GRC
NVAX
Founded
1933
1987
Country
United States
United States
Employees
N/A
N/A
Industry
Fluid Controls
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.7B
1.6B
IPO Year
1994
1996

Fundamental Metrics

Financial Performance
Metric
GRC
NVAX
Price
$61.25
$8.49
Analyst Decision
Hold
Analyst Count
0
9
Target Price
N/A
$11.33
AVG Volume (30 Days)
124.9K
4.4M
Earning Date
04-23-2026
05-07-2026
Dividend Yield
1.22%
N/A
EPS Growth
32.03
309.76
EPS
2.02
2.58
Revenue
$682,389,000.00
$1,123,479,000.00
Revenue This Year
$6.62
N/A
Revenue Next Year
$4.66
N/A
P/E Ratio
$31.00
$3.47
Revenue Growth
3.44
64.69
52 Week Low
$30.87
$5.01
52 Week High
$68.02
$11.85

Technical Indicators

Market Signals
Indicator
GRC
NVAX
Relative Strength Index (RSI) 48.96 38.12
Support Level $56.98 $8.01
Resistance Level $67.61 $9.05
Average True Range (ATR) 2.36 0.54
MACD -0.01 -0.23
Stochastic Oscillator 51.50 1.81

Price Performance

Historical Comparison
GRC
NVAX

About GRC Gorman-Rupp Company (The)

Gorman-Rupp Co designs, manufactures, and globally sells pumps & pump systems for use in water, wastewater, construction, dewatering, industrial, petroleum, original equipment, agriculture, fire protection, heating, ventilating & air conditioning, military, and other liquid-handling applications. It operates in one business segment, the manufacture & sale of pumps and pump systems, and generates revenue from the same. Geographically, it generates the majority of revenue from the United States.

About NVAX Novavax Inc.

Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. It works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The company manages its business as one operating segment, an in-house early-stage R&D business to build a pipeline of high-value assets using its technology along with seeking to enter into partnerships to drive value creation for its assets.

Share on Social Networks: